Updated:
Xeris Pharmaceuticals
Xeris Pharmaceuticals is a pharmaceutical company based in Chicago, United States, founded in 2005. It develops and commercializes ready-to-use, liquid-stable...
Xeris Pharmaceuticals
Xeris Pharmaceuticals is a pharmaceutical company based in Chicago, United States, founded in 2005. It develops and commercializes ready-to-use, liquid-stable injectables using its novel formulation technology platforms. The company has secured $115.5 million in total funding.
General information
Firm type
Biopharmaceutical
Year founded
2005
Location
Region
Asia
Country
Japan
City
Tokyo
Corporate office
Tokyo, Japan
Additional offices
Chicago, United States
Sector focus
Frequently asked questions
How is Xeris Pharmaceuticals structured?
Public records indicate the firm operates from Japan and the United States, but its legal structure — whether as a family office, asset manager, or holding company — is not specified in available sources.
Who are the key principals at Xeris Pharmaceuticals?
No named principals or leadership team members for Xeris Pharmaceuticals are available in public sources. The firm's management structure remains undisclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: